Escitalopram oxalate and Emphysema - a phase IV clinical study of FDA data

Summary:

Emphysema is reported as a side effect among people who take Escitalopram oxalate (escitalopram oxalate), especially for people who are female, 60+ old, also take Symbicort, and have B-cell small lymphocytic lymphoma.

The phase IV clinical study analyzes which people have Emphysema when taking Escitalopram oxalate. It is created by eHealthMe based on reports of 17,508 people who have side effects when taking Escitalopram oxalate from the FDA, and is updated regularly.

What is Escitalopram oxalate?

Escitalopram oxalate has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 17,930 Escitalopram oxalate users. Check the latest studies of Escitalopram oxalate.

What is Emphysema?

Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs) is found to be associated with 1,081 drugs and 1,096 conditions by eHealthMe. Check the latest studies of Emphysema.

On Jul, 06, 2026

17,508 people reported to have side effects when taking Escitalopram oxalate.
Among them, 11 people (0.06%) have Emphysema.

Could Escitalopram oxalate cause Emphysema?

Among these 11 people:

What is the gender of people who have Emphysema when taking Escitalopram oxalate? *

female: 81.82 %
male: 18.18 %

What is the age of people who have Emphysema when taking Escitalopram oxalate? *

What are other drugs people take besides Escitalopram oxalate? *

What are other side effects people have besides Emphysema? *

Pneumonia: 6 people, 54.55%
Diarrhea: 6 people, 54.55%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 45.45%
Fatigue (feeling of tiredness): 5 people, 45.45%
Thrombocytopenia (decrease of platelets in blood): 5 people, 45.45%
Hypotension (abnormally low blood pressure): 5 people, 45.45%
Malaise (a feeling of general discomfort or uneasiness): 5 people, 45.45%
Nausea (feeling of having an urge to vomit): 4 people, 36.36%
Breast Lump (localized swelling that feels different from the surrounding breast tissue): 4 people, 36.36%
Neuropathy Peripheral (surface nerve damage): 4 people, 36.36%

What are the existing conditions these people have? *

B-Cell Small Lymphocytic Lymphoma (blood cancer affecting b cells): 4 people, 36.36%
Infection: 3 people, 27.27%
Vena Cava Thrombosis (clotting of the blood in large vein carrying deoxygenated blood into the heart): 2 people, 18.18%
Svc Obstruction (superior vena cava obstruction (svco) is an uncommon complication of lung cancer): 2 people, 18.18%
Back Pain: 2 people, 18.18%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 18.18%
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 2 people, 18.18%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 2 people, 18.18%
Jugular Vein Thrombosis (clot in jugular vein): 2 people, 18.18%
Anaemia (lack of blood): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Escitalopram oxalate and have Emphysema?

- Check whether Emphysema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Escitalopram oxalate:

Escitalopram oxalate (17,930 reports)

Emphysema treatments and more:

Emphysema (29,685 reports)

Browse all side effects of Escitalopram oxalate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Emphysema:

Emphysema (1,081 drugs)

Browse all the conditions that are associated with Emphysema:

Emphysema (1,096 conditions)

Related publications that referenced our studies

O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on escitalopram oxalate (the active ingredients of Escitalopram oxalate) and Escitalopram oxalate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.